Tesamorelin
Advanced Hormone Therapy for Metabolic Optimization
Tesamorelin is a synthetic analog of growth hormone releasing hormone with FDA-studied applications in visceral fat reduction. It produces significant reductions in abdominal fat while improving lipid profiles and IGF-1 levels, making it the protocol of choice for those with metabolic concerns alongside hormone optimization goals.
What is Tesamorelin?
Tesamorelin is a synthetic GHRH analog that stimulates the production and release of endogenous growth hormone.
It is FDA-approved for the reduction of excess abdominal fat in HIV-positive patients, but is used off-label for general metabolic optimization.
The peptide works by binding to GHRH receptors in the pituitary gland, triggering natural GH release.
What are the benefits?
Tesamorelin is particularly effective at reducing visceral (abdominal) fat, which is associated with numerous health risks.
Patients may experience improved body composition, enhanced metabolism, and better cardiovascular markers.
The therapy can also support cognitive function and overall quality of life.
